Viral coinfections in COVID‐19. Issue 9 (12th June 2021)

• Record Type: Journal Article
• Authors: Aghbash, Parisa S.; Eslami, Narges; Shirvaliloo, Milad; Baghi, Hossein B.
• Other Names: Luo Guangxiang (George) guestEditor.; Ly Hinh guestEditor.; Gao Shou‐Jiang guestEditor.
• Is Part Of: Journal of medical virology. Volume 93:Issue 9(2021)
• Page Start: 5310
• Page End: 5322
• Publication Date: 2021-06-12
• Subjects: COVID‐19 -- diagnosis -- mixed infection -- SARS‐CoV‐2 -- viral coinfection -- viral respiratory tract infection -- virus infection; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.27102
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: The most consequential challenge raised by coinfection is perhaps the inappropriate generation of recombinant viruses through the exchange of genetic material among different strains. These genetically similar viruses can interfere with the replication process of each other and even compete for the metabolites required for the maintenance of the replication cycle. Due to the similarity in clinical symptoms of most viral respiratory tract infections, and their coincidence with COVID‐19, caused by SARS‐CoV‐2, it is recommended to develop a comprehensive diagnostic panel for detection of respiratory and nonrespiratory viruses through the evaluation of patient samples. Given the resulting changes in blood markers, such as coagulation factors and white blood cell count following virus infection, these markers can be of diagnostic value in the detection of mixed infection in individuals already diagnosed with a certain viral illness. In this review, we seek to investigate the coinfection of SARS‐CoV‐2 with other respiratory and nonrespiratory viruses to provide novel insights into the development of highly sensitive diagnostics and effective treatment modalities.